Compare AMPH & OLPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMPH | OLPX |
|---|---|---|
| Founded | 1996 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 971.8M | 1.0B |
| IPO Year | 2005 | 2021 |
| Metric | AMPH | OLPX |
|---|---|---|
| Price | $17.36 | $2.03 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $28.38 | $1.89 |
| AVG Volume (30 Days) | 527.4K | ★ 2.9M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $719,887,000.00 | $422,960,000.00 |
| Revenue This Year | $6.90 | $2.95 |
| Revenue Next Year | $4.64 | $3.39 |
| P/E Ratio | $130.64 | ★ N/A |
| Revenue Growth | N/A | ★ 0.07 |
| 52 Week Low | $17.03 | $0.99 |
| 52 Week High | $31.26 | $2.04 |
| Indicator | AMPH | OLPX |
|---|---|---|
| Relative Strength Index (RSI) | 33.06 | 64.38 |
| Support Level | $17.03 | $2.02 |
| Resistance Level | $24.16 | $2.04 |
| Average True Range (ATR) | 0.84 | 0.01 |
| MACD | -0.59 | -0.02 |
| Stochastic Oscillator | 1.48 | 75.00 |
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.
Olaplex Holdings Inc is a science-enabled, technology-driven beauty company. It offers science-backed solutions that improve hair health. It identifies the majority of consumers' relevant haircare concerns in collaboration with the community of professional hairstylists and consumers and strives to address them through its proprietary technology and innovation capabilities. It offers products through an omnichannel platform that serves professional, specialty retail, and DTC channels. The company derives its revenue through the sale of its hair care products. The company generates the majority of revenue from Professional sales channels followed by Specialty Retail and then DTC. Geographically the company generates the majority of its revenue from the International market.